SCTX insider trading
NasdaqGM HealthcareScribe Therapeutics, Inc.: insider trade history from SEC Form 4 filings.
About Scribe Therapeutics, Inc.
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.
Company website: www.scribetx.com
SCTX insider activity at a glance
FilingIQ tracks 14 insider transactions for SCTX in filings since Jul 27, 2026. The most recent transaction is dated Jul 28, 2026.
Across the full history, 9 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest SCTX Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SCTX?
- FilingIQ tracks 14 Form 4 insider transactions for SCTX (Scribe Therapeutics, Inc.), covering filings from Jul 27, 2026 onwards. 9 of those are dated within the last 90 days.
- Are SCTX insiders net buyers or net sellers?
- Across the full Form 4 history for SCTX, 9 transactions (64%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SCTX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is SCTX in?
- Scribe Therapeutics, Inc. (SCTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $441.87M.
Methodology & sources
Every SCTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.